Biorealize, Inc. — Form D/A
Biorealize, Inc. of PHILADELPHIA, PA, a company, filed a Form D amendment with the SEC on 2019-05-03. The offering totals $300K, of which $275K was reported sold. Industry: Other Technology.
Offering
- Filed: 2019-05-03
- Form: D/A
- Accession: 0001761302-19-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $300K
- Amount sold: $275K
- Remaining: $25K
- Investors: 1
- Date of first sale: 2018-11-26
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-327579
Issuer
- Name: Biorealize, Inc.
- CIK: 0001761302
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 3401 GRAYS FERRY AVENUE, BUILDING 176, PHILADELPHIA, PA, 19146
- Phone: 2159179660
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Orkan Moria Telhan | Executive Officer | Philadelphia, PA |
| Orkan Moria Telhan | Promoter | Philadelphia, PA |
| Karen Moria Hogan | Director | Philadelphia, PA |
| Karen Moria Hogan | Executive Officer | Philadelphia, PA |
| Karen Moria Hogan | Promoter | Philadelphia, PA |
Other filings by this issuer (2)
More